FDA Grants Priority Review to Genentech’s Tecentriq for Early Colon Cancer
SOUTH SAN FRANCISCO, Calif., June 10, 2026 Genentech, a member of the Roche Group, announced that the U.S. Food...
clinical trial
Advertisement
Airiver Treats First Patient in Pivotal CRS Balloon Trial
BROOKLYN PARK, Minn., June 11, 2026 Airiver Medical has announced the successful treatment of the first patient in its...
Formosa Pharma Expands APP13007 Reach Through Samil Deal
TAIPEI, Taiwan, June 11, 2026 Formosa Pharmaceuticals has strengthened its global ophthalmology commercialization strategy through a new exclusive licensing...
Anixa Biosciences Highlights Clinical Immunotherapy Progress at Cancer Symposium
SAN JOSE, Calif., June 11, 2026 Anixa Biosciences, Inc. announced that two of its clinical-stage cancer immunotherapy programs will...
Matter Bio Wins FDA IND Clearance for LM-LLO-TT Trial
SAN FRANCISCO, June 10, 2026 Matter Bio has announced that the U.S. Food and Drug Administration (FDA) has cleared...
Advertisements
SpinaFX Wins FDA IDE for Triojection Lumbar Disc Therapy
TORONTO, June 9, 2026 SpinaFX Medical has achieved a major regulatory milestone after receiving U.S. Food and Drug Administration...
Zetagen Therapeutics Reports Positive Phase 2a ZetaMet Results
AUSTIN, Texas, June 9, 2026 Zetagen Therapeutics announced preliminary topline results from its Phase 2a clinical study evaluating ZetaMet™...
Multi Radiance Medical Expands FDA-Cleared Laser Therapy Indications
SOLON, Ohio, June 10, 2026 Multi Radiance Medical announced that the U.S. Food and Drug Administration (FDA) has granted...
CONNECTA Therapeutics Initiates Phase IIa Study of CTH120
BARCELONA, Spain, June 10, 2026 CONNECTA Therapeutics announced the initiation of a Phase IIa clinical trial evaluating CTH120, its...
Antengene Secures China IND Clearance for ATG-201
SHANGHAI and HONG KONG, China, June 10, 2026 Antengene announced that China’s National Medical Products Administration (NMPA) has approved...
Advertisement
